Doctor profile · Federal record
Dr. Stephen Wiles, MD
Ophthalmology Physician (CMS: Ophthalmology) · Kansas City, MO
- NPI 1932136959
- Accepts Medicare
- MIPS 87.6 / 100 · 2023
- 39 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
211 Ne 54Th St
Kansas City, MO 641184362
(816) 455-2020
fax (816) 459-5690
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- June 8, 2012
- Year of graduation
- 1987 — 39 yrs since
- Specialty taxonomy
- 207W00000X — NUCC code
- State license (1)
- Missouri #R1P52
- Medicaid
- MO #203420591
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1932136959. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
216,872
Distinct HCPCS
10
Medicare allowed
$5,620,977
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2403 |
Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | 140,800 | 148 | $1 | |
J2777 |
Injection, faricimab-svoa, 0.1 mg | 49,328 | 113 | $37 | |
J2778 |
Injection, ranibizumab, 0.1 mg | 8,737 | 232 | $227 | |
67028 |
Injection of drug into eye | 3,001 | 335 | $108 | |
92134 |
Imaging of retina | 2,436 | 725 | $37 | |
92014 |
Established patient complete exam of visual system | 2,007 | 1,347 | $119 | |
83861 |
Microfluid analysis of tears | 1,958 | 743 | $22 | |
92250 |
Photography of the retina | 1,431 | 995 | $35 | |
92083 |
Exam of visual field with extended testing | 1,049 | 680 | $58 | |
92133 |
Imaging of optic nerve | 987 | 644 | $32 |
In context: peer comparison
Among 7 peers in Kansas City Ophthalmology Physician, average services per provider: 1,836. This provider delivers 118× the peer median.Open Payments
Industry payments received
All-time total
$1,532
Transactions
67
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Bausch & Lomb Americas INC. | 11 | $304.00 | |
| Abbvie INC. | 14 | $244.22 | |
| Alcon Vision LLC | 10 | $161.32 | |
| Astellas Pharma US INC | 5 | $104.08 | |
| Glaukos Corporation | 2 | $101.40 | |
| Sandoz INC. | 3 | $99.24 | |
| Harrow Eye, LLC | 4 | $97.00 | |
| Biogen, INC. | 4 | $93.12 | |
| Genentech USA, INC. | 4 | $82.51 | |
| Apellis Pharmaceuticals, INC. | 3 | $65.25 | |
| Tarsus Pharmaceuticals, INC. | 2 | $55.13 | |
| Dompe US, INC. | 2 | $46.69 | |
| Alimera Sciences, INC. | 1 | $23.13 | |
| Regeneron Healthcare Solutions, INC. | 1 | $21.54 | |
| Biotissue Holdings INC. | 1 | $19.07 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,055
Patients
1,020
Total drug cost
$513,642
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Latanoprost | Generic | 776 | 187 | $12,452 |
| Lumigan (Bimatoprost) | Brand | 565 | 138 | $247,238 |
| Prednisolone Acetate | Generic | 285 | 161 | $14,807 |
| Timolol Maleate | Generic | 264 | 78 | $3,793 |
| Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) | Brand | 225 | 61 | $6,746 |
| Combigan (Brimonidine Tartrate/Timolol) | Brand | 188 | 48 | $66,476 |
| Diclofenac Sodium | Generic | 178 | 130 | $2,059 |
| Brimonidine Tartrate | Generic | 109 | 29 | $7,114 |
| Dorzolamide Hcl | Generic | 97 | 35 | $3,051 |
| Restasis (Cyclosporine) | Brand | 86 | 24 | $89,637 |
Frequently asked questions
What is Dr. Stephen Wiles's medical specialty?
Dr. Stephen Wiles practices Ophthalmology Physician in Kansas City, MO.
Where does Dr. Stephen Wiles practice?
Dr. Stephen Wiles practices at 211 Ne 54Th St, Kansas City, MO 641184362. Office phone: 8164552020.
What is Dr. Stephen Wiles's NPI?
Dr. Stephen Wiles's National Provider Identifier (NPI) is 1932136959, issued by NPPES.
Does Dr. Stephen Wiles accept Medicare assignment?
Yes. Dr. Stephen Wiles accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Stephen Wiles commonly perform?
Top Medicare-reported procedures in 2023: Chloroprocaine hcl ophthalmic, 3% gel, 1 mg (HCPCS J2403); Injection, faricimab-svoa, 0.1 mg (HCPCS J2777); Injection, ranibizumab, 0.1 mg (HCPCS J2778). Source: CMS Medicare Physician & Other Practitioners file.